Peroxisome proliferator-activated receptor α/γ dual Agonists for the treatment of type 2 diabetes

被引：130
|
作者：
Henke, BR [1 ]
机构：
[1] GlaxoSmithKline, Metab & Viral Dis Drug Discovery Res, Res Triangle Pk, NC 27709 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2004年 / 47卷 / 17期
关键词：
D O I：
10.1021/jm030631e
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：4118 / 4127
页数：10
相关论文
共 50 条
  • [41] Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus
    Jay, Mollie A.
    Ren, Jun
    CURRENT DIABETES REVIEWS, 2007, 3 (01) : 33 - 39
  • [42] Two homoisoflavonoids act as peroxisome proliferator-activated receptor agonists
    Hsiang-Ru Lin
    Medicinal Chemistry Research, 2015, 24 : 2898 - 2905
  • [43] The Cardiovascular Effects of Peroxisome Proliferator-activated Receptor Agonists Reply
    Friedland, Sayuri
    Filion, Kristian B.
    Eisenberg, Mark J.
    AMERICAN JOURNAL OF MEDICINE, 2013, 126 (03): : E13 - E13
  • [44] Thiazolidinediones in type 2 diabetes.: Role of peroxisome proliferator-activated receptor γ (PPARγ)
    Dubois, M
    Vantyghem, MC
    Schoonjans, K
    Pattou, F
    ANNALES D ENDOCRINOLOGIE, 2002, 63 (06) : 511 - 523
  • [45] Muraglitazar - A dual peroxisome proliferator-activated receptor agonist
    Kirwin, J
    Van Amburgh, J
    FORMULARY, 2005, 40 (09) : 285 - +
  • [46] Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases
    Sharma, Vinesh
    Patial, Vikram
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [47] Novel Dual-ACTING PEROXISOME Proliferator-Activated Receptor Alpha and Gamma Agonists.
    Sharma, R.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2008, 2 (01) : 659 - 667
  • [48] Peroxisome proliferator-activated receptor-gamma agonists and diabetes: Current evidence and future perspectives
    Chiarelli, Francesco
    Di Marzio, Daniele
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (02) : 297 - 304
  • [49] Treatment of Mitochondrial Diabetes with a Peroxisome Proliferator-activated Receptor (PPAR)-gamma Agonist
    Ninomiya, Hiroyo
    Hirata, Ayumu
    Kozawa, Junji
    Nakata, Shinsuke
    Kimura, Takekazu
    Kitamura, Tetsuhiro
    Yasuda, Tetsuyuki
    Otsuki, Michio
    Imagawa, Akihisa
    Kaneto, Hideaki
    Funahashi, Tohru
    Shimomura, Iichiro
    INTERNAL MEDICINE, 2016, 55 (09) : 1143 - 1147
  • [50] Peroxisome proliferator-activated receptor (PPAR α/γ) agonists as a potential target to reduce cardiovascular risk in diabetes
    Nicholls, Stephen J.
    Uno, Kiyoko
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (02): : 89 - 94
12345